Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFUL.L Regulatory News (FUL)

  • There is currently no data for FUL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Re Alliance

7 Sep 2007 07:01

Fulcrum Pharma PLC07 September 2007 7th September 2007 FULCRUM PHARMA PLC ("the Group" or "the Company") Fulcrum and LORENZ in strategic alliance to develop and deliver "Creative eRegulatory SolutionsTM" Fulcrum Pharma plc (AIM: FUL), the drug development and regulatory servicescompany is pleased to announce the intent to form a strategic alliance withLORENZ Life Sciences Group. Fulcrum is committed to developing new products and services which enable Pharmaand Biotech companies to achieve faster regulatory approval of new medicines.LORENZ develops and markets software solutions for the life sciences industrythat are mainly geared towards submission assembly, review, publishing,validation and management for regulated environments. LORENZ and Fulcrum believethat tailored IT solutions are critically important for ensuring the quality ofpharmaceutical regulatory submissions and, if designed and appliedappropriately, can have a dramatic impact on the time to regulatory submissionand approval. As a first step in the strategic alliance, the two companies have agreed toestablish a joint sales and marketing campaign in North America and Europe toprovide tailored e-publishing solutions in this growing market. The jointproduct offering will combine the strategic regulatory and e-publishing skillsof Fulcrum with the submission management software solutions developed byLORENZ. Together, the two companies will offer Creative eRegulatory SolutionsTMin a cost-effective and tailored approach to new and existing clients. Jon Court, Chief Executive of Fulcrum Pharma, said: "Together we will be wellpositioned to meet the increasing demand for regulatory services which comprisean e-publishing component. The alliance with LORENZ will increase our capacityto deliver e-products to our clients and enhance the reach of our regulatorybusiness. We look forward to this exciting partnership and the development of aseries of new regulatory products and services" Wolfgang Witzel, President of Lorenz, said. "This partnership provides atailored solution to meet our customers' needs, combining the regulatory skillsin Fulcrum with the e-publishing expertise in LORENZ. Working with Fulcrum willenable us to enhance our regulatory product offering in a way that directlybenefits our clients. This is an exciting opportunity for both LORENZ andFulcrum" For further information, please contact: Fulcrum Pharma PLCJon Court, Chief Executive Tel: 0870 710 7152 Seymour PierceJonathan Wright Tel: 0207 107 9000 About Fulcrum Pharma plc Fulcrum Pharma plc is a drug development and regulatory services business thatprovides global expertise to achieve drug development and regulatory approvalmilestones. Fulcrum Pharma offers immediate access to a highly credible, integrateddevelopment team that provides strategic and operational leadership required toensure that new drugs move smoothly from discovery research to product approval Fulcrum Pharma is listed on the AIM Market of the London Stock Exchange havingsuccessfully floated in March 2000. About Lorenz LORENZ Life Sciences Group (www.lorenz.cc) develops and markets softwaresolutions for the Life Sciences market. LORENZ's solutions are gearedspecifically for submission assembly, review, publishing, validation andmanagement. As the number one supplier of submission management systems in theworld for US, European and Japanese submissions, LORENZ is currently the marketleader in producing eCTDs. With over 100 installations in 20 countries, LORENZhas built a reputable customer base. For more information, please contact AndreNeu, aneu@lorenz.cc in Europe and Yaprak Eisinger, yeisinger@lorenz.cc in NorthAmerica. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
7th Jun 20239:28 amRNSForm 8.5 (EPT/RI) - Fulham Shore PLC
6th Jun 20239:20 amRNSForm 8.5 (EPT/RI)
5th Jun 20239:35 amRNSForm 8.3 - The Fulham Shore Plc
2nd Jun 20231:40 pmRNSExercise of options and total voting rights
2nd Jun 20239:58 amRNSForm 8.3 - Fulham Shore Plc (The)
2nd Jun 20239:53 amRNSForm 8.5 (EPT/RI)
1st Jun 20239:24 amRNSForm 8.5 (EPT/RI)
31st May 202311:57 amRNSForm 8.5 (EPT/RI)
31st May 20238:43 amRNSForm 8.3 - The Fulham Shore Plc
30th May 202310:31 amRNSForm 8.5 (EPT/RI)
26th May 202310:18 amRNSForm 8.5 (EPT/RI)
26th May 20239:27 amRNSForm 8.3 - The Fulham Shore Plc
25th May 202312:00 pmRNSForm 8.5 (EPT/RI) - The Fulham Shore Plc
25th May 20239:25 amRNSForm 8.5 (EPT/RI)
24th May 202312:00 pmRNSForm 8.5 (EPT/RI) - The Fulham Shore Plc
24th May 20239:46 amRNSForm 8.5 (EPT/RI)
24th May 20238:15 amRNSForm 8.3 - The Fulham Shore PLC
23rd May 202312:00 pmRNSForm 8.5 (EPT/RI) - The Fulham Shore Plc
23rd May 202310:12 amRNSForm 8.5 (EPT/RI)
23rd May 20238:38 amRNSForm 8.3 - The Fulham Shore PLC
22nd May 202312:00 pmRNSForm 8.5 (EPT/RI) - The Fulham Shore Plc
22nd May 20239:51 amRNSForm 8.5 (EPT/RI)
22nd May 20238:28 amRNSForm 8.3 - The Fulham Shore PLC
19th May 202312:00 pmRNSForm 8.5 (EPT/RI) - The Fulham Shore Plc
19th May 202310:01 amRNSForm 8.5 (EPT/RI)
18th May 202312:00 pmRNSForm 8.5 (EPT/RI) - The Fulham Shore Plc
18th May 202311:48 amRNSForm 8.3 - The Fulham Shore PLC
17th May 202312:00 pmRNSForm 8.5 (EPT/RI) - The Fulham Shore Plc
17th May 202310:57 amRNSForm 8.3 - The Fulham Shore Plc
17th May 20238:22 amRNSForm 8.3 - The Fulham Shore PLC
16th May 20235:31 pmRNSRecommended Cash Acquisition update
16th May 202312:00 pmRNSForm 8.5 (EPT/RI) - The Fulham Shore Plc
16th May 20239:00 amRNSForm 8.3 - The Fulham Shore PLC
15th May 202312:00 pmRNSForm 8.5 (EPT/RI) - The Fulham Shore Plc
12th May 202312:00 pmRNSForm 8.5 (EPT/RI) - The Fulham Shore Plc
12th May 202310:20 amRNSForm 8.5 (EPT/RI)
11th May 202312:00 pmRNSForm 8.5 (EPT/RI) - The Fulham Shore Plc
11th May 202310:41 amRNSForm 8.5 (EPT/RI)
11th May 20239:30 amRNSForm 8.3 - The Fulham Shore PLC
10th May 202312:00 pmRNSForm 8.5 (EPT/RI) - The Fulham Shore Plc
10th May 20239:30 amRNSForm 8.5 (EPT/RI)
9th May 202312:00 pmRNSForm 8.5 (EPT/RI) - The Fulham Shore Plc
9th May 20239:42 amRNSForm 8.5 (EPT/RI)
9th May 20239:09 amRNSForm 8.3 - The Fulham Shore PLC
5th May 202310:19 amRNSForm 8.5 (EPT/RI)
5th May 20239:35 amRNSForm 8.3 - The Fulham Shore Plc
5th May 20239:02 amRNSForm 8.3 - The Fulham Shore PLC
4th May 202312:00 pmRNSForm 8.5 (EPT/RI) - The Fulham Shore Plc
4th May 20238:38 amRNSForm 8.3 - The Fulham Shore PLC
4th May 20238:24 amRNSForm 8.5 (EPT/RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.